Table II.
Histopathological parameter | Control | Silibinin | MTX | MTX + silibinin |
---|---|---|---|---|
Interstitial lymphocytic inflammation | 0.125 | 0.375 | 1.25a,b | 0.25c |
Interstitial fibrosis | 0 | 0 | 0.875a,b | 0c |
Type 2 pneumocyte infiltration | 0 | 0 | 0.5a,b | 0c |
Intraalveolar/interstitial macrophage existence | 0 | 0.375 | 0.5 | 0.125 |
Eosinophil existence | 0 | 0.5 | 0.875a | 0.125c |
Granuloma existence | 0 | 0 | 0.25 | 0 |
Results are presented as the mean ± standard deviation.
P<0.05, vs. control group
P<0.05, vs. silibinin group
P<0.05, vs. MTX group. MTX, methotrexate.